[1]
Wajs, A. et al. 2026. SGLT2 Inhibitors in the Management of Hypomagnesemia in Patients Without Diabetes. A Narrative Review. Journal of Education, Health and Sport. 94, (Jul. 2026), 73168. DOI:https://doi.org/10.12775/JEHS.2026.94.73168.